Faeth Therapeutics, Inc.

NASDAQ:FTH

Biotechnology

Healthcare
$8.72 +5.01%

+$1.43 today

Market cap
$224.79M
Beta
-0.31
P/E (TTM)
-0.2
EPS (TTM)
-$34.65
52W Low $7.21High $37.90

Volume 0.33M

Average 0.12M

FTH Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Faeth Therapeutics, Inc.NASDAQ: FTH

Weighted Avg Shares (Diluted) · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares (diluted) growth accelerates

Q2 FY2026 weighted avg shares (diluted) of 5.64M shares rose 347.6% year over year, ahead of the +87.9% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 335.8% from the prior quarter. Over 3 fiscal years it compounded at -6.4% a year.

Context

  • Weighted avg shares (diluted) increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +347.6% holds above the trailing-twelve-month pace of +87.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
5.64M+335.8% QoQ
Last fiscal yearDec 2025
1.26M+0.4% YoY
LTMJun 2026
2.37M+87.9% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+347.6%——
1 year+0.4%——
3-year CAGR-6.4%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
1.26M USD
Year-over-year change
+0.4%
4-year CAGR
-2.3%

Weighted Avg Shares (Diluted) vs competitors

How FTH compares with its peers on the latest reported figures

  • FTH's LTM Jun 2026 weighted avg shares (diluted) of 2.37M shares is the lowest of the 10 companies compared; the peer median is 82.44M shares.
  • Its year-over-year change of +87.9% is the 2nd highest of 10, against a peer median of +9.2%.
  • Over three fiscal years its annual growth of -6.4% compares with a peer median of +14.3%.
FTH Competitors Peer median
Weighted Avg Shares (Diluted) for FTH and competitors
Company Period LTM YoY 3-year CAGR
NUVBNuvation Bio Inc.LTM Jun 2026353.26M +9.5%+16.4%
RLAYRelay Therapeutics, Inc.LTM Jun 2026181.67M +12.1%+15.2%
TNGXTango Therapeutics, Inc.LTM Sep 2026145.89M +32.5%+9.8%
KURAKura Oncology, Inc.LTM Mar 202687.97M +1.1%+9.4%
VSTMVerastem, Inc.LTM Mar 202682.44M +107.0%+62.5%
PRLDPrelude Therapeutics IncorporatedLTM Mar 202674.4M -1.9%+17.6%
JANXJanux Therapeutics, Inc.LTM Mar 202662.14M +9.2%+14.3%
PBYIPuma Biotechnology, Inc.LTM Mar 202650.86M +3.4%+4.1%
BOLDBoundless Bio, Inc.LTM Mar 202622.38M +7.1%+0.2%
FTHFaeth Therapeutics, Inc.LTM Jun 20262.37M +87.9%-6.4%
Peer median (excluding FTH) 82.44M+9.2%+14.3%

Competitors are the stored peer set for FTH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue685K1.81M571K551K0
Gross Profit(685K)(1.81M)(571K)(551K)0
Gross Margin—————
Research & Development21.66M29.58M18.3M18.63M10.96M
Selling, General & Admin15.14M17.73M18.77M12.49M11.33M
Operating Expenses36.8M47.31M36.49M31.11M22.29M
Depreciation & Amortization685K1.81M3.68M551K139K
EBITDA(35.44M)(46.56M)(33.39M)(29.52M)(20.91M)
EBITDA Margin—————
Operating Income(37.48M)(49.12M)(37.06M)(31.66M)(22.29M)
Operating Margin—————
Interest Income800K1.78M3.62M2.55M1.24M
Interest Expense670K219K144K90K32K
Other Income / Expenses688K532K2.96M1.51M1.2M
Income Before Tax(36.79M)(48.59M)(34.1M)(30.16M)(21.09M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(36.79M)(48.59M)(34.1M)(30.16M)(21.09M)
Net Margin—————
EPS (Basic)(26.56)(31.65)(24.40)(24.01)(16.72)
EPS (Diluted)(26.56)(31.65)(24.40)(24.01)(16.72)
Weighted Avg Shares1.39M1.54M1.4M1.26M1.26M
Weighted Avg Shares (Diluted)1.39M1.54M1.4M1.26M1.26M

Faeth Therapeutics, Inc.

NASDAQ:FTH

Intrinsic Alpha fair value

Locked

Current Price

$8.72

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.